Immuneel Therapeutics Pvt. Ltd.

Immuneel Therapeutics Private Limited is an Indian clinical stage startup company founded in 2018, focused on making cell and gene therapies for cancer more affordable and accessible in India. Led by healthcare visionaries in the US and India, Immuneel is pioneering the development and delivery of these innovative treatments, specifically focusing on Chimeric Antigen Receptor T cell therapy (CAR-T cell therapy). Their mission is to address the unmet needs of India's growing cancer population by improving patient outcomes and closing the gap between the promise of these therapies and their reality.

Immuneel is committed to building a robust pipeline of cell and gene therapies, collaborating with global leaders in the field to bring cutting-edge technologies to India. They are working to create a supportive ecosystem for these therapies, including developing their own manufacturing capabilities and partnering with hospitals and healthcare professionals across India. Immuneel's efforts have garnered recognition, winning awards such as "Most Promising Cell & Gene Therapy Startup in APAC" and "Biopharma’s most promising startups 2023," demonstrating their commitment to revolutionizing cancer care in India and beyond.

Immuneel Therapeutics is an Indian company dedicated to revolutionizing cancer care in India by making cell and gene therapies, particularly CAR-T cell therapy, more accessible and affordable. They are on a mission to bridge the gap between the promise of these cutting-edge treatments and the reality of patients' access, making advanced cancer care available to a wider population.

Immuneel promotes a culture that is purpose-driven and passionate. They are committed to putting their patients first and believe in performance through passion, encouraging their employees to enjoy their work. Their dynamic and diverse team brings global best practices to innovate in the field of cell and gene therapy. Immuneel values its employees as human capital, recognizing their importance in driving change and revolutionizing cancer treatment.

Immuneel Therapeutics prioritizes diversity, equity, and inclusion by assembling a dynamic and diverse team that leverages global best practices. They are committed to creating a culture where every team member feels valued and empowered, recognizing that their people are their greatest asset. Immuneel emphasizes a purpose-driven approach, putting patients first, and promoting performance through passion, fostering a fun and inclusive work environment.